pschoffski

Patrick Schöffski is Head of the Department of General Medical Oncology and of the Laboratory of Experimental Oncology at the University Hospitals Leuven, Catholic University Leuven, Belgium. For several years he served as Secretary of the Scientific Audit Committee of the Until October 2009, he was Secretary-General of the European Organisation for Research and Treatment of Cancer (EORTC). He is currently completing his second term in the Executive Committee and Board of EORTC, and now functions as Chairman of the Clinical Research Division of EORTC. In addition he is elected again as member of the Board of Directors of the European Cancer Organisation (ECCO). He is also a member of many scientific societies including the American Society of Clinical Oncology (ASCO), American Association for Cancer Research (AACR), European Society of Medical Oncology (ESMO), German Society of Hematology and Oncology (DGHO), Belgian Society for Medical Oncology (BSMO), the Connective Tissue Oncology Society (CTOS) and the Histiocyte Society. Professor Schöffski’s main clinical interest is the treatment of solid tumours and lymphomas. He is involved in a large number of prospective clinical trials in various tumour types, including orphan malignancies, ranging from Phase 1-3. He is responsible for current prospective trials including entities such as sarcomas, urogenital and endocrine malignancies, and runs a number of non-disease specific Phase 1 trials. He has published the first EORTC Network of Core Institutes (NOCI) clinical trial, and is the lead investigator of the second NOCI study (EORTC 90101 “CREATE”). He also coordinates translational research projects associated with new drug development and sarcoma, and is involved in European Networks of Excellence with EU funding. Professor Schöffski has published more than 150 papers in international peer-reviewed oncology journals.